Lead Plaintiff Deadline: May 17, 2021
Please Upload related files below
Fill in below.
Looking for more?
CytoDyn securities were actively traded over the counter (OTC) in the United States. While the exact number of Class members is unknown to Plaintiff at this time and can be ascertained only through appropriate discovery, Plaintiff believes that there are hundreds or thousands of members in the proposed Class. Record owners and other members of the Class may be identified from records maintained by CytoDyn or its transfer agent and/or OTC Markets and may be notified of the pendency of this action by mail, using the form of notice similar to that customarily used in securities class actions.
In order to be included in the lawsuit, you must have incurred a loss on shares of CytoDyn, either: A) purchased or acquired during the class period listed above, if applicable; or B) pursuant to the Initial Public Offering (IPO) of CytoDyn, if applicable.
If you suffered a loss in CytoDyn during the relevant time frame, or pursuant to CytoDyn’s IPO if listed above, you have until May 17, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.